Photobiomodulation anti-inflammatory effect in COVID-19
Phase 1
- Conditions
- COVID-19.COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20200616047799N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
COVID-19 Pneumonia
Written consent
Older than 15 years
Exclusion Criteria
Intubated patients
Skin hypersensitivities or its history
Psoriasis
Inflammation of the site of PBM implementation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method